Guardant Health, Inc. (GH) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 12.81B |
| Enterprise Value | 14.14B |
| P/E Ratio | -38 |
| PEG Ratio | 110.58 |
| Price/Sales Ratio | 15.81 |
| Price/Book Ratio | -93.4 |
| Enterprise/Revenue | 16.48 |
| Enterprise/EBITDA | -45.52 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.4 |
| Operating Margin | -0.41 |
| Return On Assets | -0.23 |
| Return On Equity | 1.84 |
| Revenue | 982.02M |
| Revenue/Share | 8.23 |
| Gross Profit | 633.01M |
| EBITDA | -373.91M |
| Net Income | -416.28M |
| Diluted EPS | -3.32 |
| Total Cash | 1.1B |
| Total Cash/Share | 8.4 |
| Total Debt | 1.7B |
| Total Debt/Equity | -9.41 |
| Current Ratio | 4.68 |
| Book Value Per Share | -1.38 |
| 52-Week Change | 165.36 |
| 52-Week High | 135 |
| 52-Week Low | 40.35 |
| Moving Average 50 Days | 106.63 |
| Moving Average 200 Days | 94.23 |
| Average Volume | 2.24M |
| Shares Outstanding | 132.6M |
| % Held by Institutions | 106.76 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |